Healthcare -
Biotechnology - NASDAQ - US
$ 7.47
1.41 %
$ 160 M
Market Cap
-1.59
P/E
ENTA - CASH FROM OPERATIONS
Cash from Operations ENTA - Enanta Pharmaceuticals, Inc.
-78.8 M
LAST VALUE
3.61%
2 YEAR CAGR
-16.03%
5 YEAR CAGR
-17.23%
10 YEAR CAGR